Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands
Waltham, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN) today announced that is has extended a long-term supply agreement with Purolite Life Sciences for the manufacture of Protein A ligands at Repligen’s facilities in Waltham, MA and Lund, Sweden. Repligen is the main strategic supplier of Protein A ligands to Purolite, an emerging player in the Protein A resin market with its Praesto® line of modern agarose-based, high-flow chromatography resins. Pursuant to the agreement, Repligen will supply Protein A ligands to Purolite through November 2022, with an option for renewal through 2025. Protein A chromatography remains the gold standard for monoclonal antibody purification, consistently providing outstanding results. Steve Tingley, VP of Sales for Repligen said, “We are delighted that Purolite has made the decision to extend our current supply agreement, which ensures the supply of high quality Protein A ligands to Purolite for the next five to eight
